Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
36.56
-0.54 (-1.46%)
At close: Sep 15, 2025, 4:00 PM EDT
36.15
-0.41 (-1.12%)
After-hours: Sep 15, 2025, 4:02 PM EDT
KNSA Market Cap
KNSA has a market cap or net worth of $2.70 billion as of September 15, 2025. Its market cap has increased by 39.87% in one year.
Market Cap
2.70B
Enterprise Value
2.40B
1-Year Change
39.87%
Ranking
Category
Stock Price
$36.56
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $2.70B, an increase of 185.90%. That is a compound annual growth rate of 15.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 2.75B | 92.51% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |